>
White House Correspondents' Dinner Shooter's Link to NASA and Other Curiosities
US Military Ends 72-Year Mandatory Flu Shot Policy
3 Million Ounces of Gold and 28 Million Ounces of Silver Taken Out the Back Door
Researcher wins 1 bitcoin bounty for 'largest quantum attack' on underlying tech
Interceptor-Drone Arms-Race Emerges
A startup called Inversion has introduced Arc, a space-based vehicle...
Mining companies are using cosmic rays to find critical minerals
They regrew a severed nerve - by shortening a bone.
New Robot Ants Work Like Real Insects To Build And Dismantle On Their Own
Russian scientists 'are developing the world's first drug to delay ageing' months after
Sam Altman's World ID Expands Biometric Identity Checks
China Tests Directed Energy Beam That Recharges Drones Mid-Flight
Jurassic Park might arrive sooner than expected, just with Dinobots.

This exciting new study shows that "proton therapy" is a stunningly effective noninvasive treatment against high-risk childhood cancers – and it comes with minimal side effects.
Unlike traditional photon radiation using x-rays, proton radiation therapy (PRT) is a non-invasive, precise cancer treatment that uses a beam of protons moving at very high speeds to destroy the DNA of cancer cells, killing them and preventing them from multiplying.
Highly targeted, PRT has significant promise for treating tumors in very young children and may reduce radiation exposure to healthy, developing tissue that may result in lifelong impacts.
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma who were treated with proton radiation therapy.
Not only did they find that proton therapy was effective at reducing tumors, they also found that it demonstrated minimal toxicity to surrounding organs.
The study is published online in the International Journal of Radiation Oncology.
"These data are extremely encouraging and could be a game-changer for a number of reasons," said lead author Christine Hill-Kayser, Chief of the Pediatric Radiation Oncology Service at Penn Medicine.